Stockscreener 앱 받기
0.23%
시간 외 거래:
Mckesson Corporation 주식(MCK)의 최신 뉴스
Pharmacy Leaders Enhance Culture with Continuous Learning | McKesson ideaShare - Drug Topics
McKesson Defied The Doubters (Including Me) -- And Could Do It Again (NYSE:MCK) - Seeking Alpha
Expert: Leaders Build Comprehensive Pharmacy Strategies | McKesson ideaShare - Drug Topics
Is McKesson Corporation a good long term investmentUnmatched market performance - Autocar Professional
What makes McKesson Corporation stock attractive to long term investorsConsistently superior profits - jammulinksnews.com
Britt Vitalone Joins Align Technology’s Board of Directors - Medical Product Outsourcing
What drives McKesson Corporation stock priceBreakthrough financial growth - Autocar Professional
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
What analysts say about McKesson Corporation stockTriple-digit return opportunities - Autocar Professional
McKesson Corporation Stock Analysis and ForecastFree Market Volatility Navigation Tips - jammulinksnews.com
Here's Why McKesson (MCK) is a Strong Value Stock - Yahoo Finance
TAKANOCK NAMES CRAIG MCKESSON CHIEF COMMERCIAL OFFICER TO ACCELERATE GROWTH STRATEGY - Yahoo Finance
McKesson Amplify Reaches All 50 States - McKesson
Pharmacy Automation Market Surges with 10.12% CAGR; AI & Retail Pharmacy Demand Transform Dispensing in 2025 - GlobeNewswire Inc.
Rated R Meaning Nausea Relief Reliefband® Sport Wrist BandMcKesson Rated R Superstar Cope Logo - roarmag.org
Is McKesson (MCK) an Overlooked Dividend Stock in the Pharma Sector for 2025? - MSN
14 Best Pharma Dividend Stocks to Buy in 2025 - Insider Monkey
Q&A: Pharmacist's Voices Help Propel Industry Changes | McKesson ideaShare - Drug Topics
What to Expect From McKesson's Q1 2026 Earnings Report - MSN
Published on: 2025-07-18 12:27:46 - jammulinksnews.com
Lobbying Update: $460,000 of MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS lobbying was just disclosed - Quiver Quantitative
McKesson Disputes Rite Aid Trust's Antitrust Claim Demands - Law360
McKesson Corporation's Q1 2026 Earnings Preview and Stock PerformanceNews and Statistics - IndexBox
What To Expect From McKesson's Q1 2026 Earnings Report - Barchart.com
McKesson Keeps Delivering As Specialty Drugs Drive Growth - Finimize
McKesson (MCK): Morgan Stanley Raises Price Target to $810 | MCK Stock News - GuruFocus
McKesson (MCK) Sees Price Target Boost from Morgan Stanley | MCK Stock News - GuruFocus
McKesson ideaShare Empowers Independent Pharmacies to Innovate and Thrive - Yahoo Finance
Mckesson CEO Tyler S. Brian sells $13.7m in stock By Investing.com - Investing.com South Africa
Mckesson CEO Tyler S. Brian sells $13.7m in stock - Investing.com
Synergy (NASDAQ: SNYR) Strategic Partnership w/ McKesson - openPR.com
Conference Recap: McKesson ideaShare Showcases Power of Independent Pharmacies - Drug Topics
McKesson (MCK) Partners with Synergy CHC for Canadian Distributi - GuruFocus
Synergy CHC Corp. (NASDAQ: SNYR) Secures Retail Deals with McKesson Canada and Others as FOCUSfactor Expansion Surges Across North America - The Manila Times
Government Contract Update: $1B payment to MCKESSON CORPORATION - Quiver Quantitative
McKesson ideaShare 2025: Pharmacy of the Year Finalist Keri Bates Reflects on Teamwork, Community, and the Road Ahead - Pharmacy Times
Independent Pharmacies Face Mounting Challenges in Modern Health Care Landscape | McKesson ideaShare - Drug Topics
McKesson Corporation (MCK): If It Was Down, I’d Say “Fill Her Up,” Says Jim Cramer - MSN
McKesson's Commitment to Independent Community Pharmacies Takes Center Stage | McKesson ideaShare - Drug Topics
McKesson ideaShare 2025: Pharmacy Technicians Drive Efficiency and Care - Pharmacy Times
Expert Discusses McKesson's Approach to Supporting Community Pharmacies | McKesson ideaShare - Drug Topics
How McKesson Ruling Will Inform Interpretations Of The TCPA - Law360
McKesson ideaShare 2025: Pharmacy Owner Keri Bates on Career Growth, Technician Pathways, and Building a Sustainable Pharmacy Team - Pharmacy Times
Financial Planning Remains Core Focus to Create Thriving Pharmacy Business | McKesson ideaShare - Drug Topics
Is McKesson Corporation (NYSE:MCK) Trading At A 34% Discount? - Yahoo Finance
Evercore ISI Adjusts Price Target on McKesson to $800 From $760, Maintains Outperform Rating - MarketScreener
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
0.03%
13.64%
자본화:
|
볼륨(24시간):